Ameriprise Financial Inc Standard Biotools Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $39,603 - $66,878	-10,910 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $2,200 - $2,964	-400 Reduced 3.54%	10,910 $72,000
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $354 - $638	-90 Reduced 0.79%	11,310 $51,000
Q4 2020 Feb 12, 2021	SELL	$5.45 - $8.65 $100,525 - $159,549	-18,445 Reduced 61.8%	11,400 $69,000
Q3 2020 Nov 16, 2020	BUY	$4.34 - $11.43 $83,501 - $219,913	19,240 Added 181.42%	29,845 $222,000
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $19,619 - $56,100	10,605 New	10,605 $42,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.